2023 was a tricky year with the biopharma market, with quite a few organizations downsizing and restructuring their workforces to remain afloat. You will find signs of recovery, as mergers and acquisitions picked up over the pharmaceutical and everyday living sciences industry inside the latter Section of 2023 and also https://sites.google.com/view/bio-sites/blog